<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Yestino - The Signal · Foghorn Therapeutics</title><link>https://yestino.com/zh-CN/entities/foghorn-therapeutics-9bb9ae</link><description>与 Foghorn Therapeutics 相关的全部事件</description><language>zh-CN</language><atom:link href="https://yestino.com/zh-CN/entities/foghorn-therapeutics-9bb9ae/feed.xml" rel="self" type="application/rss+xml"/><item><title>Foghorn Therapeutics is cutting 40% of its workforce after Eli Lilly ends cancer drug partnership</title><link>https://yestino.com/zh-CN/events/foghorn-therapeutics-is-cutting-40-of-its-workforce-after-el-a0abb3</link><guid isPermaLink="true">https://yestino.com/zh-CN/events/foghorn-therapeutics-is-cutting-40-of-its-workforce-after-el-a0abb3</guid><pubDate>Fri, 02 Oct 2026 13:50:39 GMT</pubDate><description>The companies are scrapping two collaborative cancer programs and don&apos;t anticipate any further joint projects
来源：Quartz</description></item></channel></rss>